⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer

Official Title: A Clinical Study Evaluating the Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer - A Multicenter, Randomized, Open-label, Positive-controlled, Superiority Phase III Clinical Trial in China

Study ID: NCT04185649

Study Description

Brief Summary: To evaluate the safety and efficacy of BAT8001 for the treatment of HER2-positive advanced breast cancer, using lapatinib in combination with capecitabine as the positive control drug.

Detailed Description: This is a multicenter, randomized, open-label, positive-controlled, superiority phase III clinical study. The object is to evaluate the safety and efficacy of BAT8001 for the treatment of HER2-positive advanced breast cancer, using lapatinib in combination with capecitabine as the positive control drug. Eligible subjects will be randomized to the experimental or control group in a 1:1 ratio and stratified by the number of HER2-positive advanced/metastatic breast cancer treatment regimens (0, 1 VS \> 1) and lesion site (organ VS non-organ).

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China

Anhui Provincial Hospital, Hefei, Anhui, China

Beijing Hospital, Beijing, Beijing, China

Beijing Shijitan Hospital, Beijing, Beijing, China

Peking union medical college hospital, Beijing, Beijing, China

Chinese PLA General Hospital, Peking, Beijing, China

Chongqing Cancer Hospital, Chongqing, Chongqing, China

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Foshan City No. 1 People's Hospital, Foshan, Guangdong, China

Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong, China

Sun Yat-sen Memorial Hospital. SYSU, Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

Peking University Shenzhen Hospital, Shenzhen, Guangdong, China

Shenzhen People's Hospital, Shenzhen, Guangdong, China

The First Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China

The Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China

Liuzhou workers hospital, Liuzhou, Guangxi, China

The First Affiliated Hospital of Hainan Medical College, Haikou, Hainan, China

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

The First Affiliated Hospital of Henan University of science and technology, Luoyang, Henan, China

The First Affiliated Hospital of Xixiang Medical College, Xinxiang, Henan, China

Hubei Cancer Hospital, Wuhan, Hubei, China

Tongji Hospital of Tongji Medical College of HUST, Wuhan, Hubei, China

Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

Yichang Central Hospital, Yichang, Hubei, China

Hunan Cancer Hospital, Changsha, Hunan, China

Xiangya Hospital Central South University, Changsha, Hunan, China

Jiangsu Cancer Hospital, Nanning, Jiangsu, China

Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China

Yancheng City No. 1 People's Hospital, Yancheng, Jiangsu, China

Jiangxi Cancer Hospital, Nanchang, Jiangxi, China

The Third Hospital of Nanchang, Nanchang, Jiangxi, China

Jilin Cancer Hospital, Chang chun, Jilin, China

The First Bethune Hospital of Jilin University, Changchun, Jilin, China

Jinzhou Central Hospital, Jinzhou, Liaoning, China

Liaoning Cancer Hospital, Shenyang, Liaoning, China

General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China

Shandong Cancer Hospital, Jinan, Shandong, China

Linyi Cancer Hospital, Linyi, Shandong, China

Weifang People's Hospital, Weifang, Shandong, China

Fudan University Shanghai Cancer Hospital, Shanghai, Shanghai, China

Shanghai General Hospital, Shanghai, Shanghai, China

Shanghai Sixth People's Hospital, Shanghai, Shanghai, China

The Second Hospital of Anhui Medical University, Shanghai, Shanghai, China

Shanxi Cancer Hospital, Xi'an, Shanxi, China

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China

West China Hospital of Sichuan University, Chengdu, Sichuan, China

Yunnan Cancer Hospital, Kunming, Yunnan, China

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Taizhou Hispotal of Zhejiang Province, Taizhou, Zhejiang, China

Contact Details

Name: Shusen Wang, M.D.

Affiliation: Sun Yat-sen University

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: